Mutual Funds

DSP Healthcare Fund-Reg(G)
Equity | Very High | Equity - Sectoral Fund - Pharma & Health Care

45.82 +0.24
NAV(₹) as on 6/11/2026

0.52%
1D

16.95%
1Y

20.35%
3Y

15.05%
5Y

DSP Healthcare Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio: 2.05	Launch Date: 30 Nov 2018
Exit Load: 0.50% on or before 1M, Nil after 1M	AUM: ₹ 3,750.04 Crs
Lock-in: Nil	Investing Style: Mid Growth
Portfolio Price To Book Value: 6.72	Min. Investment: SIP : ₹ 100.00 Lumpsum : ₹ 100.00
Scheme Benchmark: NA
Fund Manager: Chirag Dagli

FUND OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

LATEST ASSET & PORTFOLIO ALLOCATION		Others		Equity
as on 30/9/2026		7.82 %		92.18 %

TOP HOLDINGS

Ipca Laboratories Ltd.

8.13 %

Sun Pharmaceutical Industries Ltd.

7.44 %

Cipla Ltd.

7.18 %

Sai Life Sciences Ltd.

6.52 %

Gland Pharma Ltd.

6.15 %

Apollo Hospitals Enterprise Ltd.

6.07 %

Alkem Laboratories Ltd.

4.75 %

Divi's Laboratories Ltd.

4.17 %

Cohance Lifesciences Ltd.

3.79 %

Alembic Pharmaceuticals Ltd.

3.18 %

See All Holding

ALLOCATION BY MARKET CAP (Equity)

ALLOCATION BY RATING (Debt & Others)

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs

64.95 %

Hospital & Healthcare Servic

16.49 %

Business Support

1.35 %

Insurance

1.02 %

Medical Equipment/Supplies/A

0.14 %

See All Sectors

PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year	2021-22	2022-23	2023-24	2024-25	2025-26
NAV (31/3/2026)	21.88	20.91	32.76	37.40	36.15
Net Assets (Rs Crores)	1,29,146.07	1,20,210.08	2,35,231.83	3,01,876.45	2,89,176.19
Scheme Returns(%)(Absolute)	13.12	-4.60	56.86	13.41	-1.49
B'mark Returns(%)(Absolute)	NA	NA	NA	NA	NA
Category Rank	44/75	61/76	20/90	17/102	56/120

RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details	Inception Date	Aum(₹ Crs)	1Y	3Y	5Y	Since Inception
WOC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.09 +0.12	6/2/2024	₹ 926.55	20.80%	-	-	21.52%
PGIM India Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 12.10 +0.09	6/12/2024	₹ 130.33	20.04%	-	-	10.45%
Bajaj Finserv Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.85 +0.02	27/12/2024	₹ 405.14	20.08%	-	-	9.53%
Baroda BNP Paribas Health and Wellness Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.81 +0.04	27/6/2025	₹ 487.35	12.23%	-	-	5.91%
Bandhan Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.18 +0.08	28/11/2025	₹ 325.07	-	-	-	11.78%
Invesco India Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.22 +0.23	7/9/2026	₹ 435.52	-	-	-	2.20%
Kotak Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.24 +0.02	11/12/2023	₹ 825.14	26.31%	-	-	20.61%
Tata India Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 32.88 +0.22	28/12/2015	₹ 1,499.08	6.88%	17.82%	13.66%	11.58%
Nippon India Pharma Fund(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 574.10 +5.18	5/6/2004	₹ 9,166.4	11.70%	17.93%	13.77%	19.78%
ITI Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 18.19 +0.09	8/11/2021	₹ 266.05	11.40%	18.44%	-	12.72%